Multiple Ascending Doses Study of CG400549

NCT01848470 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CG400549 640mg
DRUG: CG400549 320 mg
DRUG: CG400549 640 mg
DRUG: CG400549 960 mg
DRUG: Placebo 640mg
DRUG: Placebo 320mg
DRUG: placebo 960 mg
DRUG: Placebo 640mg

Sponsor

CrystalGenomics, Inc.